EYE 4.00% 18.0¢ nova eye medical limited

Ann: USA Sales Update, page-51

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 16,462 Posts.
    lightbulb Created with Sketch. 4411
    No worries. And yeah, that FY23 result is definitely a bit deceptive because of the massive non-cash one off expense. Makes it look like costs blew out last year when in reality they actually shrunk quite a bit as a percentage of sales. At the rate they are going it really shouldn't be difficult for them to be breakeven or profitable this financial year. They appear to have very good operating leverage so a bit of scale is all they really need (and clearly they are definitely getting that scale!)
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.